
Neeraj Sharma
Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )
| Most Active Art Unit | 2659 |
| Art Unit(s) | 2659, 2626 |
| Total Applications | 582 |
| Issued Applications | 475 |
| Pending Applications | 51 |
| Abandoned Applications | 71 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 103092
[patent_doc_number] => 07723476
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Anticalins'
[patent_app_type] => utility
[patent_app_number] => 11/224071
[patent_app_country] => US
[patent_app_date] => 2005-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15736
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723476.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224071
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224071 | Anticalins | Sep 12, 2005 | Issued |
Array
(
[id] => 5711239
[patent_doc_number] => 20060052584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/224297
[patent_app_country] => US
[patent_app_date] => 2005-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8973
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052584.pdf
[firstpage_image] =>[orig_patent_app_number] => 11224297
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/224297 | Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof | Sep 12, 2005 | Abandoned |
Array
(
[id] => 9323115
[patent_doc_number] => 08658133
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-25
[patent_title] => 'Methods and compositions relating to alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 11/574367
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 24218
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 701
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11574367
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574367 | Methods and compositions relating to alzheimer's disease | Aug 25, 2005 | Issued |
Array
(
[id] => 4456803
[patent_doc_number] => 07893197
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Relaxin-3 chimeric polypeptides and their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 11/660883
[patent_app_country] => US
[patent_app_date] => 2005-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 32001
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/893/07893197.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660883
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660883 | Relaxin-3 chimeric polypeptides and their preparation and use | Aug 24, 2005 | Issued |
Array
(
[id] => 4813366
[patent_doc_number] => 20080193997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Liquid Preparation of Physiologically Active Peptide'
[patent_app_type] => utility
[patent_app_number] => 11/660406
[patent_app_country] => US
[patent_app_date] => 2005-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17213
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193997.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660406
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660406 | Liquid Preparation of Physiologically Active Peptide | Aug 23, 2005 | Abandoned |
Array
(
[id] => 6931188
[patent_doc_number] => 20050282223
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'TR3-specific binding agents and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 11/196919
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19019
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282223.pdf
[firstpage_image] =>[orig_patent_app_number] => 11196919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/196919 | TR3-specific binding agents and methods for their use | Aug 3, 2005 | Abandoned |
Array
(
[id] => 5820412
[patent_doc_number] => 20060024725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Oncofetal fibronectin as a marker for pregnancy-related indications'
[patent_app_type] => utility
[patent_app_number] => 11/193857
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 165158
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024725.pdf
[firstpage_image] =>[orig_patent_app_number] => 11193857
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/193857 | Oncofetal fibronectin as a marker for pregnancy-related indications | Jul 28, 2005 | Abandoned |
Array
(
[id] => 5710959
[patent_doc_number] => 20060052304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Method for remodeling bone and related sutures'
[patent_app_type] => utility
[patent_app_number] => 11/191824
[patent_app_country] => US
[patent_app_date] => 2005-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9729
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052304.pdf
[firstpage_image] =>[orig_patent_app_number] => 11191824
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/191824 | Method for remodeling bone and related sutures | Jul 26, 2005 | Abandoned |
Array
(
[id] => 602281
[patent_doc_number] => 07432044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-07
[patent_title] => 'Methods and compositions for modulating hepatocyte growth factor activation'
[patent_app_type] => utility
[patent_app_number] => 11/189230
[patent_app_country] => US
[patent_app_date] => 2005-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 46137
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/432/07432044.pdf
[firstpage_image] =>[orig_patent_app_number] => 11189230
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/189230 | Methods and compositions for modulating hepatocyte growth factor activation | Jul 24, 2005 | Issued |
Array
(
[id] => 5632227
[patent_doc_number] => 20060148697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Methods for treating and preventing brain cancers'
[patent_app_type] => utility
[patent_app_number] => 11/180668
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 10640
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148697.pdf
[firstpage_image] =>[orig_patent_app_number] => 11180668
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/180668 | Methods for treating and preventing brain cancers | Jul 13, 2005 | Abandoned |
Array
(
[id] => 7220063
[patent_doc_number] => 20050260669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease'
[patent_app_type] => utility
[patent_app_number] => 11/174166
[patent_app_country] => US
[patent_app_date] => 2005-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29293
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20050260669.pdf
[firstpage_image] =>[orig_patent_app_number] => 11174166
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/174166 | Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease | Jun 30, 2005 | Abandoned |
Array
(
[id] => 5694186
[patent_doc_number] => 20060154333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Pan-HER antagonists and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/172611
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6511
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154333.pdf
[firstpage_image] =>[orig_patent_app_number] => 11172611
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/172611 | Pan-HER antagonists and methods of use | Jun 29, 2005 | Issued |
Array
(
[id] => 5794009
[patent_doc_number] => 20060014690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Epidermal growth factor receptor antagonists and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/172610
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 7949
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014690.pdf
[firstpage_image] =>[orig_patent_app_number] => 11172610
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/172610 | Epidermal growth factor receptor antagonists and methods of use | Jun 29, 2005 | Issued |
Array
(
[id] => 6925393
[patent_doc_number] => 20050238648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Composition and method for trating inflammatory disorders'
[patent_app_type] => utility
[patent_app_number] => 11/157387
[patent_app_country] => US
[patent_app_date] => 2005-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26226
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238648.pdf
[firstpage_image] =>[orig_patent_app_number] => 11157387
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/157387 | Composition and method for trating inflammatory disorders | Jun 19, 2005 | Abandoned |
Array
(
[id] => 4658125
[patent_doc_number] => 20080026987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-31
[patent_title] => 'Use of Liver-Selective Glucokinase Activators'
[patent_app_type] => utility
[patent_app_number] => 11/629711
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8346
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20080026987.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629711
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629711 | Use of Liver-Selective Glucokinase Activators | Jun 16, 2005 | Abandoned |
Array
(
[id] => 5591403
[patent_doc_number] => 20060040855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Low efficacy gonadotropin agonists and antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/152601
[patent_app_country] => US
[patent_app_date] => 2005-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13498
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040855.pdf
[firstpage_image] =>[orig_patent_app_number] => 11152601
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/152601 | Low efficacy gonadotropin agonists and antagonists | Jun 13, 2005 | Abandoned |
Array
(
[id] => 4802585
[patent_doc_number] => 20080014172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Use of Il-17 in the Treatment of Fertility-Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 11/596416
[patent_app_country] => US
[patent_app_date] => 2005-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21688
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20080014172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596416
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596416 | Use of Il-17 in the Treatment of Fertility-Related Disorders | May 30, 2005 | Abandoned |
Array
(
[id] => 7018744
[patent_doc_number] => 20050220763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma'
[patent_app_type] => utility
[patent_app_number] => 11/136966
[patent_app_country] => US
[patent_app_date] => 2005-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5630
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20050220763.pdf
[firstpage_image] =>[orig_patent_app_number] => 11136966
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/136966 | Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma | May 24, 2005 | Abandoned |
Array
(
[id] => 5894373
[patent_doc_number] => 20060002912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis'
[patent_app_type] => utility
[patent_app_number] => 11/130428
[patent_app_country] => US
[patent_app_date] => 2005-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7131
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002912.pdf
[firstpage_image] =>[orig_patent_app_number] => 11130428
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/130428 | Methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis | May 15, 2005 | Issued |
Array
(
[id] => 4698838
[patent_doc_number] => 20080221022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from It, as Therepeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis'
[patent_app_type] => utility
[patent_app_number] => 11/596493
[patent_app_country] => US
[patent_app_date] => 2005-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16954
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596493
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596493 | Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis | May 15, 2005 | Issued |